159 related articles for article (PubMed ID: 26120967)
1. Cytokine and Adipokine Levels in Patients with Premalignant Oral Lesions or in Patients with Oral Cancer Who Did or Did Not Receive 1α,25-Dihydroxyvitamin D3 Treatment upon Cancer Diagnosis.
Young MR; Levingston C; Johnson SD
Cancers (Basel); 2015 Jun; 7(3):1109-24. PubMed ID: 26120967
[TBL] [Abstract][Full Text] [Related]
2. An Inflammatory Cytokine Milieu is Prominent in Premalignant Oral Lesions, but Subsides when Lesions Progress to Squamous Cell Carcinoma.
Woodford D; Johnson SD; De Costa AM; Young MR
J Clin Cell Immunol; 2014 Jun; 5(3):. PubMed ID: 25419481
[TBL] [Abstract][Full Text] [Related]
3. Immunological modulation by 1α,25-dihydroxyvitamin D3 in patients with squamous cell carcinoma of the head and neck.
Walker DD; Reeves TD; de Costa AM; Schuyler C; Young MR
Cytokine; 2012 Jun; 58(3):448-54. PubMed ID: 22450225
[TBL] [Abstract][Full Text] [Related]
4. MART-10, a novel vitamin D analog, inhibits head and neck squamous carcinoma cells growth through cell cycle arrest at G0/G1 with upregulation of p21 and p27 and downregulation of telomerase.
Chiang KC; Yeh CN; Hsu JT; Chen LW; Kuo SF; Sun CC; Huang CC; Pang JH; Flanagan JN; Takano M; Kittaka A; Juang HH; Yang SW; Chen TC
J Steroid Biochem Mol Biol; 2013 Nov; 138():427-34. PubMed ID: 24044969
[TBL] [Abstract][Full Text] [Related]
5. Transient immunological and clinical effectiveness of treating mice bearing premalignant oral lesions with PD-1 antibodies.
Levingston CA; Young MR
Int J Cancer; 2017 Apr; 140(7):1609-1619. PubMed ID: 27914100
[TBL] [Abstract][Full Text] [Related]
6. Effect of the premalignant and tumor microenvironment on immune cell cytokine production in head and neck cancer.
Johnson SD; De Costa AM; Young MR
Cancers (Basel); 2014 Apr; 6(2):756-70. PubMed ID: 24698959
[TBL] [Abstract][Full Text] [Related]
7. Treatment to sustain a Th17-type phenotype to prevent skewing toward Treg and to limit premalignant lesion progression to cancer.
Young MR; Levingston CA; Johnson SD
Int J Cancer; 2016 May; 138(10):2487-98. PubMed ID: 26756968
[TBL] [Abstract][Full Text] [Related]
8. Indomethacin Treatment of Mice with Premalignant Oral Lesions Sustains Cytokine Production and Slows Progression to Cancer.
Johnson SD; Young MR
Front Immunol; 2016; 7():379. PubMed ID: 27713748
[TBL] [Abstract][Full Text] [Related]
9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
10. Suppressive Effect of 1α,25-Dihydroxyvitamin D3 on Th17-Immune Responses in Kidney Transplant Recipients With Tacrolimus-Based Immunosuppression.
Chung BH; Kim BM; Doh KC; Min JW; Cho ML; Kim KW; Yang CW
Transplantation; 2017 Jul; 101(7):1711-1719. PubMed ID: 28107277
[TBL] [Abstract][Full Text] [Related]
11. Decreased immunosuppressive actions of 1α, 25-dihydroxyvitamin D
Liu W; Li H; Hao Y; Li Y; Lv M; Xue F; Liu X; Zhang L; Yang R
Mol Immunol; 2016 Oct; 78():89-97. PubMed ID: 27614264
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of 1α,25-dihydroxyvitamin D3 on effector CD4+ T cell induced injury in human renal proximal tubular epithelial cells.
Chung BH; Kim BM; Doh KC; Cho ML; Kim KW; Yang CW
PLoS One; 2017; 12(2):e0172536. PubMed ID: 28245293
[TBL] [Abstract][Full Text] [Related]
13. Regulatory effects of 1alpha,25-dihydroxyvitamin D3 on the cytokine production of human peripheral blood lymphocytes.
Willheim M; Thien R; Schrattbauer K; Bajna E; Holub M; Gruber R; Baier K; Pietschmann P; Reinisch W; Scheiner O; Peterlik M
J Clin Endocrinol Metab; 1999 Oct; 84(10):3739-44. PubMed ID: 10523023
[TBL] [Abstract][Full Text] [Related]
14. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.
Chen Z; Malhotra PS; Thomas GR; Ondrey FG; Duffey DC; Smith CW; Enamorado I; Yeh NT; Kroog GS; Rudy S; McCullagh L; Mousa S; Quezado M; Herscher LL; Van Waes C
Clin Cancer Res; 1999 Jun; 5(6):1369-79. PubMed ID: 10389921
[TBL] [Abstract][Full Text] [Related]
15. MART-10, a newly synthesized vitamin D analog, represses metastatic potential of head and neck squamous carcinoma cells.
Yang SW; Tsai CY; Pan YC; Yeh CN; Pang JH; Takano M; Kittaka A; Juang HH; Chen TC; Chiang KC
Drug Des Devel Ther; 2016; 10():1995-2002. PubMed ID: 27382252
[TBL] [Abstract][Full Text] [Related]
16. Increased presence of CD34+ cells in the peripheral blood of head and neck cancer patients and their differentiation into dendritic cells.
Garrity T; Pandit R; Wright MA; Benefield J; Keni S; Young MR
Int J Cancer; 1997 Nov; 73(5):663-9. PubMed ID: 9398043
[TBL] [Abstract][Full Text] [Related]
17. Characterization of osteoarthritic human knees indicates potential sex differences.
Pan Q; O'Connor MI; Coutts RD; Hyzy SL; Olivares-Navarrete R; Schwartz Z; Boyan BD
Biol Sex Differ; 2016; 7():27. PubMed ID: 27257472
[TBL] [Abstract][Full Text] [Related]
18. 1,25-dihydroxyvitamin D3 downregulates aromatase expression and inflammatory cytokines in human macrophages.
Villaggio B; Soldano S; Cutolo M
Clin Exp Rheumatol; 2012; 30(6):934-8. PubMed ID: 23253631
[TBL] [Abstract][Full Text] [Related]
19. Effect of 1,25-(OH)2D3 on Proliferation of Fibroblast-Like Synoviocytes and Expressions of Pro-Inflammatory Cytokines through Regulating MicroRNA-22 in a Rat Model of Rheumatoid Arthritis.
Fan P; He L; Hu N; Luo J; Zhang J; Mo LF; Wang YH; Pu D; Lv XH; Hao ZM; Ding CH; Xue WJ; Li Y
Cell Physiol Biochem; 2017; 42(1):145-155. PubMed ID: 28528333
[TBL] [Abstract][Full Text] [Related]
20. Serum Pro-Inflammatory Cytokines and Leptin as Potential Biomarkers for Treatment Response and Toxicity in Locally Advanced Squamous Cell Carcinoma of the Head and Neck.
Alrehaili AA; Gharib AF; Bakhuraysah MM; Alharthi A; Alsalmi O; Alsaeedi FA; Alhakami RA; Alasmari KA; Mohammed N; Elsawy WH
Diseases; 2024 Mar; 12(3):. PubMed ID: 38534979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
